Bioinformatics Core
生物信息学核心
基本信息
- 批准号:10703344
- 负责人:
- 金额:$ 55.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-12 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAntibiotic TherapyAntimicrobial ResistanceBacterial GenomeBar CodesBioinformaticsCRISPR interferenceCellsCommunitiesCustomDNA analysisDNA methylation profilingDataDatabasesDemocracyDepositionDevelopmentEducational process of instructingEducational workshopFailureGenesGenomeGenomic DNAGenomicsGenotypeGoalsGuppyHeterogeneityHigh-Throughput Nucleotide SequencingImmunityInstitutionLeadershipLibrariesMapsMediatingMetagenomicsMethodologyMethodsMicrobeModificationNomenclatureNucleic AcidsOrthologous GenePerformancePopulationPreparationProtein IsoformsPublishingRNAReproducibilityResearchResearch PersonnelResource SharingResourcesSalmonShotgunsStreamTrainingTranscriptTreatment FailureUniversitiesVisualizationautomated analysiscomparative genomicsdata explorationdata sharingdata to knowledgedeep sequencingdroplet sequencingflexibilityforestgraphical user interfacehost-microbe interactionsinnovationmembermethylomenanoporepathogenportabilitypublic databasescreeningtooltranscriptome sequencingtransposon sequencingweb app
项目摘要
SUMMARY
The development of antimicrobial resistance involves the rise of heterogeneity in populations of
microbes by uncertain mechanisms. This Unit is focused on the understanding the rise of cell-
states that we call enablers that give rise to treatment failure. Identifying these cell states
requires the development, sharing, implementation support, and analytical training of a broad
suite of genomics and bioinformatics methods for each scientific project. The key function of this
Core is to integrate methods, data, and support team members with their analysis goals. This
Genomics and Bioinformatics core commits to provide this support and analytical leadership by
establishing rigorous workflows for a wide range of nucleic acid library preparations. In addition,
we will develop and share a range of innovative bioinformatic analyses methods for assembly,
quantitative read-mapping, community profiling, and portable bacterial genome nomenclature.
Most importantly for the broader impact of this project, we will enable iterative, reproducible
inquiry of ‘omics data with bioinformatics training for trainees, staff, and collaborators throughout
the team.
In Aim 1, we develop and provide methods to analyze genome fragments or amplicons, including
gDNA sequencing, barcode sequencing, Tn-Seq, droplet-TnSeq (dTnseq), Deplete-seq (called
Enabler-seq here) and CRISPRi/Tn-seq. We will also continue development and economization
of RNAseq methods such as RNAtag-Seq, dual-host-microbe RNA-seq (dRNA-Seq), 3’-end map-
sequencing (3pMap / Term-Seq), and will develop the use of direct RNA sequencing to identify
transcript modifications or isoforms that drive enabler types. In Aim 2, we develop and support
implementation of a variety of analysis methods to turn these ‘omics data into knowledge,
including an innovative pipeline called Aerobio that addresses the challenge of integrating multiple
data and analysis streams and new inference platforms like LOLIPoP and BFClust. In Aim 3 we
focus on democratizing data exploration throughout the team and ultimately for the broader
research community by offering training on portable methods. These efforts include a new, flexible
ortholog identification tool with a graphical interface (OrthoPathDB) built upon our published
ShinyOmics, shared resources for distributed installation, and regular training in genomic DNA
analysis, RNAseq, amplicon sequencing, and host immunity - microbe interactions. In summary,
this Core will consistently generate high-quality data and provide unfettered access to both wet-
bench and bioinformatic methodology, as well as their workflow status, via open sharing and
training.
概括
抗菌耐药性的发展涉及在
微生物通过不确定的机制。该单元的重点是理解细胞的兴起
指出我们称会导致治疗失败的推动力。识别这些细胞状态
需要广泛的开发,共享,实施支持和分析培训
每个科学项目的基因组学和生物信息学方法套件。此关键功能
核心是将方法,数据和支持团队成员与他们的分析目标集成。这
基因组学和生物信息学核心致力于通过
为广泛的核酸文库制剂建立严格的工作流程。此外,
我们将开发和共享一系列创新的生物信息学分析方法,用于组装,
定量阅读图,社区分析和便携式细菌基因组命名法。
最重要的是,对于该项目的更广泛影响,我们将实现迭代,可再现的
查询“对培训,员工和合作者的生物信息学培训的OMICS数据
团队。
在AIM 1中,我们开发并提供了分析基因组片段或扩增子的方法,包括
GDNA测序,条形码测序,TN-Seq,液滴-TNSEQ(DTNSEQ),DEPLETE-SEQ(计算
在此处启用seq)和crispri/tn-seq。我们还将继续发展和经济
RNASEQ方法,例如rnatag-seq,双架 - 摩卡RNA-seq(DRNA-Seq),3'-End Map-
测序(3pmap / term-seq),并将开发直接RNA测序的使用以识别
驱动启用器类型的成绩单修改或同工型。在AIM 2中,我们开发和支持
实施各种分析方法将这些'OMIC数据转化为知识,
包括一个名为Aerobio的创新管道,该管道解决了整合多个的挑战
数据和分析流以及诸如lolipop和bfclust之类的新推理平台。在目标3中我们
专注于整个团队的数据探索,并最终以更广泛的方式进行民主化
通过提供便携式方法培训来研究社区。这些努力包括一个新的灵活
用图形接口(Orthopathdb)构建的直系同源识别工具
发光,共享用于分布式安装的资源以及基因组DNA的定期培训
分析,RNASEQ,扩增子测序和宿主免疫史 - 微生物相互作用。总之,
该核心将始终产生高质量的数据,并提供对这两个湿的不受限制访问
通过公开共享和
训练。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Vaughn Cooper其他文献
Vaughn Cooper的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Vaughn Cooper', 18)}}的其他基金
2023 Microbial Population Biology Gordon Research Conference and Gordon Research Seminar
2023年微生物种群生物学戈登研究会议暨戈登研究研讨会
- 批准号:
10753797 - 财政年份:2023
- 资助金额:
$ 55.93万 - 项目类别:
EvolvingSTEM: authentic classroom research curriculum to enhance inclusion and agency in modern life science
EvolvingSTEM:真实的课堂研究课程,以增强现代生命科学的包容性和能动性
- 批准号:
10664572 - 财政年份:2023
- 资助金额:
$ 55.93万 - 项目类别:
Attacking failure of antibiotic treatment by targeting antimicrobial resistance enabler cell-states
通过针对抗生素耐药性细胞状态来应对抗生素治疗的失败
- 批准号:
10703342 - 财政年份:2022
- 资助金额:
$ 55.93万 - 项目类别:
Drug resistance enablers and their role in antibiotic treatment failure
耐药性促成因素及其在抗生素治疗失败中的作用
- 批准号:
10703347 - 财政年份:2022
- 资助金额:
$ 55.93万 - 项目类别:
Molecular mechanisms of adaptive diversity in Burkholderia biofilms
伯克霍尔德杆菌生物膜适应性多样性的分子机制
- 批准号:
8818035 - 财政年份:2015
- 资助金额:
$ 55.93万 - 项目类别:
Molecular mechanisms of adaptive diversity in Burkholderia biofilms
伯克霍尔德杆菌生物膜适应性多样性的分子机制
- 批准号:
9258441 - 财政年份:2015
- 资助金额:
$ 55.93万 - 项目类别:
Ecological population structure and emergence of virulent Vibrio parahaemolyticus
副溶血弧菌的生态种群结构和强毒力的出现
- 批准号:
7573549 - 财政年份:2009
- 资助金额:
$ 55.93万 - 项目类别:
Ecological population structure and emergence of virulent Vibrio parahaemolyticus
副溶血弧菌的生态种群结构和强毒力的出现
- 批准号:
7847548 - 财政年份:2009
- 资助金额:
$ 55.93万 - 项目类别:
相似海外基金
A Randomized Pilot and Feasibility Study of a cultuRE-Directed approach to Urinary traCT Infection symptoms in older womeN: a mixed methods evaluation - the REDUCTION trial
针对老年女性尿路感染症状的文化导向方法的随机试验和可行性研究:混合方法评估 - REDUCTION 试验
- 批准号:
10586250 - 财政年份:2023
- 资助金额:
$ 55.93万 - 项目类别:
Development of Targeted Antipseudomonal Bactericidal Prodrugs
靶向抗假单胞菌杀菌前药的开发
- 批准号:
10678074 - 财政年份:2023
- 资助金额:
$ 55.93万 - 项目类别:
Development of a model of Gonococcal conjunctivitis for vaccine evaluations
开发用于疫苗评估的淋菌性结膜炎模型
- 批准号:
10740430 - 财政年份:2023
- 资助金额:
$ 55.93万 - 项目类别:
Bacteriophage as a predictive biomarker in chronic Pseudomonas airway disease
噬菌体作为慢性假单胞菌气道疾病的预测生物标志物
- 批准号:
10723956 - 财政年份:2023
- 资助金额:
$ 55.93万 - 项目类别:
Clinical decision support algorithm to optimize management of respiratory tract infection in children attending primary health facilities in Kilimanjaro Region, Tanzania
用于优化坦桑尼亚乞力马扎罗地区初级卫生机构儿童呼吸道感染管理的临床决策支持算法
- 批准号:
10734148 - 财政年份:2023
- 资助金额:
$ 55.93万 - 项目类别: